Professor David Kerr highlights how the NCI’s global program is closing cancer care gaps worldwide with affordable, innovative technologies.

Updated surveillance protocols target severe hypercalcemia risk in patients receiving burosumab for X-linked hypophosphatemia ...

Anthelmintic drug, levamisole, is being reviewed by the EMA’s safety committee for its links to debilitating brain disease, ...

EMA issues warning that a type of membrane used during continuous renal replacement therapy may sequester the antifungal agent caspofungin and reduce its effectiveness.

Prefrontal cortex biopsies taken for research purposes during deep brain stimulation procedures appear to be safe, new ...

A global consensus overrides fear of harming the fetus and makes some novel recommendations for the use of medication during ...

A mindfulness-based emotion regulation training program lowers daily stress and rumination and boosts coping skills and sleep ...

Tofacitinib demonstrates effectiveness in treating ulcerative colitis-associated peripheral spondyloarthritis.

Pericoronary adipose tissue attenuation measured using coronary CT angiography correlates with levels of IL-6 and TNF alpha ...

Lung cancer researchers are emphasizing the importance of combating the misconception that only smokers are at risk for lung ...

Many heart failure diagnoses occur in the emergency room or inpatient setting, according to lead study author Omar ...

Despite the increased use of advanced medical therapies in Crohn’s disease, the 5-year rate of a third surgery remains ...